ABUSE OF DANGEROUS LICIT AND ILLICIT DRUGS-

PSYCHOTROPICS, PHENCYCLIDINE (PCP), AND TALWIN

4

SEP 1 8 1979

EXCHANGE & GIFT
COPY DIVISION

HEARINGS

BEFORE THE

SELECT COMMITTEE ON
NARCOTICS ABUSE AND CONTROL

HOUSE OF REPRESENTATIVES

NINETY-FIFTH CONGRESS

SECOND SESSION

AUGUST 8, 10, SEPTEMBER 19, AND OCTOBER 6, 1978

Printed for the use of the

Select Committee on Narcotics Abuse and Control

SCNAC-95-2-22

United States, Congress. Louse. Select Committee
11 Narcotics Abuse and Control,

#

ABUSE OF DANGEROUS LICIT AND ILLICIT DRUGS-
PSYCHOTROPICS, PHENCYCLIDINE (PCP), AND TALWIN

HEARINGS

BEFORE THE

SELECT COMMITTEE ON
NARCOTICS ABUSE AND CONTROL

HOUSE OF REPRESENTATIVES

NINETY-FIFTH CONGRESS

SECOND SESSION

AUGUST 8, 10, SEPTEMBER 19, AND OCTOBER 6, 1978

38-999 O

Printed for the use of the

Select Committee on Narcotics Abuse and Control

SCNAC-95-2-22

U.S. GOVERNMENT PRINTING OFFICE

WASHINGTON: 1979

5.

No3 1978e

Tuesday, August 8, 1978...

Testimony of Hon. Norman Y. Mineta, a Representative in Congress

from the State of California..

Testimony of Lee I. Dogoloff, Associate Director, Domestic Policy

Staff, the White House__

Testimony of Peter B. Bensinger, Administrator, Drug Enforcement

Administration; accompanied by James M. Smith, Special Agent,

Los Angeles Regional Office, DEA__

Testimony of Dorynne Czechowicz, M.D., Special Assistant to the

Director of the Division of Community Assistance, and Chairman

of the National Institute on Drug Abuse PCP Task Force; accom-

panied by Dr. Robert C. Petersen, NIDA_

Afternoon session, August 8, 1978-

Testimony of Hon. Lloyd Bentsen, a Senator from the State of Texas_

Testimony of Iola Scrafford, director, crossroads program, Fairfax, Va.;

accompanied by Edward Rugenstein and Steve Rugenstein--

Testimony of Paul Luisada, M.D., psychiatrist and Deputy Medical

Director of the Area D Community Mental Health Center, National

Institute of Mental Health__

Testimony of Frank E. Minyard, M.D., coroner of Orleans Parish,

New Orleans, La..

Testimony of Lt. James Elkins, director of vice/narcotics division,

Montgomery County, Md., Department of Police..

Submissions for the record:

Letter to Chairman Wolff from Lee I. Dogoloff, dated October 13,

1978__

79

Letter to Chairman Wolff from William S. Apple, American

Pharmaceutical Association_.

83

Letter to Chairman Wolff from Lee I. Dogoloff, dated October 17,

1978__

84

Thursday, August 10, 1978-

Testimony of Charles Brannan, former detailman with Hoffmann-

La Roche Inc. __

119

121

Testimony of Dr. Leonard G. Schifrin, professor of economics, Col-

lege of William and Mary, Williamsburg, Va_-_-

149

Testimony of Jonathan O. Cole, M.D., psychopharmacology program,

McLean Hospital, Belmont, Mass.

Afternoon session, August 10, 1978_

151

167

Testimony of Irwin Lerner, vice president of marketing, Hoffmann-

La Roche Inc..

168

Testimony of Ms. Sue Boe, assistant vice president, consumer affairs

of the Pharmaceutical Manufacturers Association; accompanied by

Bruce J. Brennan, vice president and general counsel

Testimony of Robert F. Maronde, M.D., professor of medicine,

section of chemical pharmacology, University of Southern

California

195

199